A unique product development partnership seeks to address the need for new therapeutics for Chagas disease by developing and testing vaccine candidate antigens that would eventually comprise a ...

Benznidazole shows better efficacy than posaconazole in patients with chronic Chagas disease, a long-term follow-up study ...

which have been patented and are progressing toward the first-ever clinical trial of Chagas disease vaccine candidates. "Dr. Farani's more sensitive approach to DNA extraction represents a ...

which have been patented and are progressing toward the first-ever clinical trial of Chagas disease vaccine candidates. "Dr. Farani’s more sensitive approach to DNA extraction represents a ...

These programs include protein vaccines for hookworm (Na-GST-1, Na-APR-1), Chagas disease (Tc24, TSA-1), SARS (RBD protein), and Leishmaniasis (LdNH-36). After basic R&D has been performed and ...